The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Arie Kappetein

Showing 1-20 of 54 articles
Geographical variations in left main coronary artery revascularisation: a pre-specified analysis of the EXCEL trial
Myat A, Hildick-Smith D, de Belder A, Trivedi U, Crowley A, Morice M, Kandzari D, Lembo N, Brown W, Serruys P, Kappetein A, Sabik J, Stone G
July 2, 2021 | 10.4244/EIJ-D-21-00338
Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy
Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein A, Head S, Onuma Y, Serruys P
May 16, 2021 | 10.4244/EIJ-D-20-00170
Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial
Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein A, Dressler O, Stone G
December 18, 2020 | 10.4244/EIJ-D-19-00686
Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial
Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein A, Sabik J, Dressler O, Mehran R, Sharma S, Stone G
June 25, 2020 | 10.4244/EIJ-D-19-00851
Prognostic performance of the Society of Thoracic Surgeons risk score in patients with left main coronary artery disease undergoing revascularisation: a post hoc analysis of the EXCEL trial
Thuijs D, Habib R, Head S, Puskas J, Taggart D, Stone G, Zhang Z, Serruys P, Sabik J, Kappetein A
May 20, 2020 | 10.4244/EIJ-D-19-00417
Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial
Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas J, Kandzari D, Banning A, Morice M, Taggart D, Sabik J, Serruys P, Kappetein A, Stone G
August 9, 2019 | 10.4244/EIJ-D-19-00263
Coronary interventions
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial
Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice M, Leon M, Kandzari D, Mehran R, Lembo N, Banning A, Merkely B, Kappetein A, Sabik J, Serruys P, Stone G
November 20, 2018 | 10.4244/EIJ-D-18-00711
Interventions for valvular disease
One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial
Serruys P, Modolo R, Reardon M, Miyazaki Y, Windecker S, Popma J, Chang Y, Kleiman NS, Lilly S, Amrane H, Boonstra P, Kappetein A, Onuma Y, Søndergaard L, Van Mieghem N
October 19, 2018 | 10.4244/EIJ-D-18-00460
Stable CAD
The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial
Milojevic M, Head S, Mack M, Mohr F, Morice M, Dawkins K, Holmes D, Serruys P, Kappetein A
May 20, 2018 | 10.4244/EIJ-D-17-00620
Coronary interventions
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?
Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein A, Mohr F, Colombo A, Feldman T, Morice M
September 20, 2017 | 10.4244/EIJ-D-16-00991
Interventions for valvular disease
How should I treat an Edwards SAPIEN 3 aortic valve embolisation during a transaortic transcatheter aortic valve implantation?
Fournier S, Monney P, Roguelov C, Ferrari E, Eeckhout E, Mueller O, Durko A, Van Mieghem N, Kappetein A, Margey R
July 20, 2017 | 10.4244/EIJ-D-16-00592
Interventions for valvular disease
A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team
Amrane H, Porta F, Van Boven A, Kappetein A, Head S
June 2, 2017 | 10.4244/EIJ-D-16-00103
Coronary interventions
Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial
Milojevic M, Head S, Andrinopoulou E, Serruys P, Mohr F, Tijssen J, Kappetein A
May 15, 2017 | 10.4244/EIJ-D-16-00745
Coronary interventions
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial
Kappetein A, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G
September 18, 2016 | 10.4244/EIJV12I7A141
Interventions for valvular disease
Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve
Sawaya F, Kappetein A, Wisser W, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Wimmer-Greinecker G, Serruys P, Lefèvre T
August 20, 2016
Interventions for valvular disease
VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies
Erlebach M, Head S, Mylotte D, Leon M, Serruys P, Kappetein A, Martucci G, Généreux P, Windecker S, Lange R, Piazza N
June 20, 2016 | 10.4244/EIJV12I3A60
Coronary interventions
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease
Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P
June 10, 2016 | 10.4244/EIJV12I2A36
Interventions for valvular disease
Current decision making and short-term outcome in patients with degenerative aortic stenosis: the Pooled-RotterdAm-Milano-Toulouse In Collaboration Aortic Stenosis survey
Van Mieghem N, Dumonteil N, Chieffo A, Roux Y, van der Boon R, Giustino G, Hartman E, Aga Y, de Jong L, Ghanem M, Marcheix B, Cavazza C, Carrié D, Colombo A, Kappetein A, de Jaegere P, Tchétché D
February 12, 2016 | 10.4244/EIJV11I10A253
Interventions for valvular disease
Measuring risk in valvular interventions: from low risk to futility
Kappetein A
September 17, 2015 | 10.4244/EIJV11SWA6
Transcatheter Lotus valve implantation in a regurgitant SAPIEN 3 valve
Van Mieghem N, Rodriguez-Olivares R, Kappetein A, de Jaegere P
July 20, 2015 | 10.4244/EIJY15M02_06

Latest news

NEW ISSUE
EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…
July 20, 2021
Editorial
Treatment of secondary mitral regurgitation in patients with heart failure
Marco Metra et al
July 27, 2021
JAA
This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....
July 20, 2021
Editorial
Coronary flow capacity: where to next?
Nils P. Johnson
July 20, 2021
Ahead of print
Joint EAPCI/ACVC expert consensus document on pVADs
July 20, 2021
NEW
EuroIntervention's new impact factor!
July 1, 2021
STATE OF THE ART
Completeness of Revascularisation in ACS Patients with Multivessel Disease
Valeria Paradies et al.
June 25, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke